FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1640891000168106: anifrolumab 300 mg / 2 mL injection, 2 mL vial (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2023. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4767811000168110 anifrolumab 300 mg / 2 mL injection, 2 mL vial (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4767821000168115 anifrolumab 300 mg/2 mL injection, vial en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
anifrolumab 300 mg/2 mL injection, vial Is a anifrolumab true Inferred relationship Some
anifrolumab 300 mg/2 mL injection, vial Is a medicinal product unit of use true Inferred relationship Some
anifrolumab 300 mg/2 mL injection, vial has manufactured dose form injection true Inferred relationship Some
anifrolumab 300 mg/2 mL injection, vial has unit of use vial true Inferred relationship Some 394121100
anifrolumab 300 mg/2 mL injection, vial has Australian BoSS anifrolumab true Inferred relationship Some 1271177837
anifrolumab 300 mg/2 mL injection, vial has intended active ingredient anifrolumab true Inferred relationship Some 1271177837
Inbound Relationships Type Active Source Characteristic Refinability Group
Saphnelo 300 mg/2 mL injection, 2 mL vial Is a True anifrolumab 300 mg/2 mL injection, vial Inferred relationship Some
anifrolumab 300 mg/2 mL injection, 2 mL vial has MPUU True anifrolumab 300 mg/2 mL injection, vial Inferred relationship Some 1954863745

Reference Sets

Medicinal product unit of use reference set

Back to Start